OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q1 2015$830,000,000
+4.7%
596,971
+70.9%
0.02%
+12.5%
Q3 2013$793,000,000349,4000.02%
Other shareholders
GALENA BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders